COMMUNIQUÉS West-GlobeNewswire

Spero Announces Appointment of David P. Southwell to its Board of Directors
01/02/2018
CAMBRIDGE, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]
Spectral Medical Announces the Appointment of Chief Financial Officer
01/02/2018
TORONTO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT ), a Phase III company developing a treatment for patients with endotoxemic septic shock, today announced that Richard Wieland II has been [...]
Delcath Announces Satisfaction of 2016 Convertible Note
01/02/2018
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has satisfied all of [...]
Evolve BioSystems Partners With King’s College London to Resolve Gut Dysbiosis in C-Section Delivered Infants
01/02/2018
DAVIS, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Evolve BioSystems, Inc., a leader in advancing infant nutrition and health through restoration of the gut microbiome, announced today a collaboration with King’s College [...]
First Patient Enrolled in AlloSure Registry
01/02/2018
BRISBANE, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Invuity to Present at Leerink Global Healthcare Conference
01/02/2018
SAN FRANCISCO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at [...]
ZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic Markets
01/02/2018
KEEGO HARBOR, Mich., Feb. 01, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products derived from [...]
Making Breast Cancer Surgery Easier for Women: Over 25,000 Women in U.S. Experienced Wire-free Breast Tumor Localization with SAVI SCOUT®
01/02/2018
ALISO VIEJO, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., the world leader in wire-free breast localization, announced that over 230 hospitals across the United States have collectively performed over [...]
New Clinical Program at Amedisys for Heart Failure Patients Significantly Lowers Risks of Hospitalizations and Readmissions
01/02/2018
BATON ROUGE, La., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Patients diagnosed with heart failure who were enrolled in the new Amedisys Heart Failure program in 2016 and 2017 were significantly less likely to be hospitalized [...]
Progressive Care CEO, S. Parikh Mars Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
01/02/2018
PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD) (the “company”), a healthcare services and technology company, today announced, the release of CEO, Shital Mars’ interview on Uptick Newswire [...]
Actinium Pharmaceuticals Announces Acceptance of Abstract for AACR Annual Meeting Highlighting Superior In Vivo Survival Data for Actinium Labelled Daratumumab Versus Unlabeled Daratumumab, A Blockbuster Product
01/02/2018
- Poster to present additional data showcasing ability of Actinium’s AWE Technology to yield a potential biobetter of daratumumab, a blockbuster CD38 targeted therapy for multiple myeloma NEW YORK, Feb. 01, 2018 (GLOBE [...]
Emerald Health Therapeutics Achieves Tier 1 Listing on TSX Venture Exchange
01/02/2018
VICTORIA, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) has announced that in accordance with TSX Venture Exchange Policy 2.5, the Company has met the [...]
Dr. Ernest Loumaye, CEO of ObsEva SA returns to work following a personal leave for medical reasons
01/02/2018
Geneva, Switzerland and Boston, MA - February 1, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Nabriva Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference
01/02/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
01/02/2018
U.S. Patient Utilization Grew 33%, Year Over Year DANVERS, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support and recovery technologies, today [...]
AxoGen, Inc. to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
01/02/2018
ALACHUA, Fla., Feb. 01, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries , today announced that Karen Zaderej [...]
RedHill Biopharma to Present at BIO CEO & Investor Conference
01/02/2018
TEL-AVIV, Israel and RALEIGH, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Vical and Mycoses Study Group Education and Research Consortium Establish Collaboration to Advance Vical’s Novel Antifungal VL-2397 for the Treatment of Invasive Aspergillosis
01/02/2018
SAN DIEGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) and the Mycoses Study Group Education and Research Consortium (MSGERC) today announced the establishment of a collaboration to advance [...]
Coloplast delivers solid Q1 interim results and continues to take market share
01/02/2018
Coloplast delivered 8% organic revenue growth and an EBIT margin of 31% at constant exchange rates in the first quarter of the 2017/18 financial year. The results were in line with the company’s guidance. Coloplast [...]

Pages